Cerebras is two companies wearing one ticker. One is a genuinely differentiated silicon engineering shop with an architectural edge that the rest of the industry is now scrambling to copy. The other is a revenue base so concentrated that until roughly two months ago it had, functionally, two customers — both in Abu Dhabi. Any honest read of CBRS has to hold both at once, and the second one deserves far more weight than the momentum around the stock suggests.

The headline says OpenAI is leaning toward delaying its IPO to 2027. The price action says something narrower: the most leveraged claim on that listing just repriced. SoftBank fell as much as 13% in Tokyo, the worst session since August 2024, while OpenAI’s own business did not change at all.

That gap between the news and the reaction is the entire story. This was never a fundamentals event. OpenAI filed a confidential S-1 on June 8, revenue is still growing, and the company told regulators it had not settled on timing. What moved was the calendar, and the calendar is the only thing SoftBank shareholders were actually long.

The dominant worry about the AI buildout is a timing mismatch: roughly $700 billion of hyperscaler capital expenditure committed in 2026, against application revenues that critics call nascent. The bear frames this as a financing problem waiting to happen. The bull case is narrower and more mechanical, and it is worth stating in its strongest form: the capex curve and the revenue curve are shaped to cross, and the crossover is arriving now rather than at the end of the decade.